journal article·2026-01-07Open access

Clinical and Radiographic Outcomes of Vital Pulp Therapy Using Resin-Modified Versus Conventional Calcium Silicate-Based Materials: A Systematic Review and Meta-Analysis

Alberto Cabrera-Fernández, Laura Dominguez-Dominguez, Antonio Pérez-Pérez, João Miguel Marques Santos, Aránzazu Díaz-Cuenca, Daniel Torres-Lagares, Diana B. Sequeira, Juan J. Segura-Egea, Jenifer Martín-González

Abstract

Vital pulp therapy (VPT) is increasingly recognised as a biologically driven alternative to root canal treatment in teeth with deep caries and a vital pulp diagnosis. Resin-modified calcium silicate-based materials (RM-CSMs) were introduced to combine the bioactivity of traditional cements with improved handling and immediate light-curing, but their biological performance remains debated. Objectives: This systematic review and meta-analysis aimed to evaluate the clinical and radiographic outcomes of VPT performed with RM-CSMs compared with conventional non-resin-modified calcium silicate-based materials (NRM-CSMs) Methods: PRISMA Guidelines were followed to carry out this systematic review. Electronic databases (Medline, Embase, Scopus, and Web of Science) were searched up to October 2025 for randomised clinical trials evaluating indirect pulp capping, direct pulp capping, or pulpotomy. Nine trials met the inclusion criteria. Meta-analyses were performed for TheraCal LC, the only RM-CSM with sufficient clinical evidence. The risk of bias was assessed using the RoB 2 Tool. The certainty of evidence was assessed using GRADE. Results: Pooled results showed no significant differences in overall clinical–radiographic success between RM-CSMs and NRM-CSMs at 90 or 180 days. At 360 days, a trend favouring NRM-CSMs emerged, though not statistically significant. Dentine bridge formation at 360 days was significantly lower with TheraCal LC. Conclusions: Current RM-CSMs demonstrate comparable short-term success to conventional materials but still present biological limitations, particularly regarding long-term reparative outcomes. NRM-CSMs remain the preferred option when maximal bioactivity and predictable dentinogenesis are required
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Endodontics and Root Canal Treatments · Dental materials and restorations · Dental Erosion and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Stomatology, Endodontic Section, School of Dentistry, University of Sevilla, 41009 Sevilla, Spain

Department of Medical Biochemistry and Molecular Biology and Immunology, School of Medicine, University of Seville, 41004 Seville, Spain

Institute of Endodontics, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal

Materials Science Institute of Seville (ICMS), Joint CSIC-University of Seville Center, 41092 Sevilla, Spain

References (66)

Show source-provided references
1. European Society of Endodontology Position Statement: Management of Deep Caries and the Exposed Pulp10.1111/iej.13080 ↗
2. Endodontic Position Statements in Deep Caries Management Highlight Need for Clarification and Consensus for Patient Benefit10.1111/iej.13619 ↗
3. Treatment Outcomes of 4 Vital Pulp Therapies in Mature Molars10.1016/j.joen.2017.12.010 ↗
4. Vital Pulp Therapy in Vital Permanent Teeth with Cariously Exposed Pulp: A Systematic Review10.1016/j.joen.2010.12.004 ↗
5. Activation of Human Dental Pulp Progenitor/Stem Cells in Response to Odontoblast Injury10.1016/j.archoralbio.2004.11.009 ↗
6. Efficacy of Direct Pulp Capping for Management of Cariously Exposed Pulps in Permanent Teeth: A Systematic Review and Meta-Analysis10.1111/iej.13449 ↗
7. Sealing Ability of a Mineral Trioxide Aggregate for Repair of Lateral Root Perforations10.1016/S0099-2399(06)81282-3 ↗
8. Bioactive Tri/Dicalcium Silicate Cements for Treatment of Pulpal and Periapical Tissues10.1016/j.actbio.2019.05.050 ↗
9. Leaching and Cytotoxicity of Bismuth Oxide in ProRoot MTA—A Laboratory Investigation10.1111/iej.14101 ↗
10. Efficacy of Mineral Trioxide Aggregate Versus Biodentine as a Direct Pulp Capping Material in Carious Human Mature Permanent Teeth: A Systematic Review
11. In Vitro Biocompatibility and Bioactivity of Calcium Silicate-Based Bioceramics in Endodontics (Review)10.3892/ijmm.2021.4961 ↗
12. Mineral Trioxide Aggregate: A Comprehensive Literature Review—Part I: Chemical, Physical, and Antibacterial Properties10.1016/j.joen.2009.09.006 ↗
13. BISCO, Inc. (2023). TheraCal LC Safety Data Sheet, BISCO, Inc.
14. TheraCal LC: From Biochemical and Bioactive Properties to Clinical Applications10.1155/2018/3484653 ↗
15. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial10.1016/j.joen.2017.06.025 ↗
16. Light-Cured Tricalcium Silicate Toxicity to the Dental Pulp10.1016/j.joen.2017.07.010 ↗
17. Comparative Study of Pulpal Responses to Pulpotomy with ProRoot MTA, RetroMTA, and TheraCal in Dogs’ Teeth10.1016/j.joen.2015.04.007 ↗
18. Light-cured calcium silicate based-cements as pulp therapeutic agents: A meta-analysis of clinical studies10.1016/j.jebdp.2022.101776 ↗
19. In Vitro Evaluation of Sealing Ability of Biodentine and TheraCal PT in Primary Molars
20. Clinical Influencing Factors of Vital Pulp Therapy on Pulpitis Permanent Teeth with 2 Calcium Silicate-Based Materials: A Randomized Clinical Trial10.1097/MD.0000000000038015 ↗
21. Treatment Outcomes and Prognostic Factors of Direct Pulp Capping in Permanent Teeth: A Systematic Review and Meta-Analysis10.14744/eej.2024.93723 ↗
22. RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials10.1136/bmj.l4898 ↗
23. Efficacy of Different Calcium Silicate Materials as Pulp-Capping Agents: Randomized Clinical Trial10.1016/j.jds.2020.08.016 ↗
24. Clinical and Radiographic Evaluation of Indirect Pulp Capping with Three Different Materials: A 2-Year Follow-up Study
25. Dört Direkt Pulpa Kaplama Materyalinin Klinik Takip Sonuçlarının Değerlendirilmesi10.15311/selcukdentj.829044 ↗
26. Comparative Evaluation of Different Direct Pulp Capping Agents in Carious Tooth: An in Vivo Study10.4103/jcd.jcd_71_21 ↗
27. Effectiveness of TheraCal LC versus MTA in vital pulp therapy of cariously-exposed young permanent molars: Five-year follow up of a randomised clinical trial
28. Comparative Evaluation of the Efficacy of TheraCal LC, Mineral Trioxide Aggregate, and Biodentine As Direct Pulp Capping Materials in Patients With Pulpal Exposure in Posterior Teeth: A Triple-Blinded Randomized Parallel Group Clinical Trial
29. Comparative Evaluation of Dual-Cure Resin (TheraCal PT) and Biodentine in Coronal Pulpotomy of Patients with Symptoms Indicative of Irreversible Pulpitis: A Randomized Clinical Trial10.4103/JCDE.JCDE_280_24 ↗
30. Comparative Evaluation of Four Different Calcium-Based Medicaments as an Indirect Pulp Capping Agent: An in Vivo Study10.4103/JCDE.JCDE_507_25 ↗
31. Tomographic Evaluation of Reparative Dentin Formation after Direct Pulp Capping with Ca(OH)2, MTA, Biodentine, and Dentin Bonding System in Human Teeth10.1016/j.joen.2015.03.017 ↗
32. Keys to Clinical Success with Pulp Capping: A Review of the Literature10.2341/09-132-0 ↗
33. A Meta-Analysis of Calcium Silicate-Based Cements and Calcium Hydroxide as Promoters of Hard Tissue Bridge Formation10.1111/iej.14210 ↗
34. Guan, X., Zhou, Y., Yang, Q., Zhu, T., Chen, X., Deng, S., Zhang, D., Guan, X., Zhou, Y., and Yang, Q. (2021). Vital Pulp Therapy in Permanent Teeth with Irreversible Pulpitis Caused by Caries: A Prospective Cohort Study. J. Pers. Med., 11.10.3390/jpm11111125 ↗
35. Use of Vital Pulp Therapies in Primary Teeth 2024
36. Prognosis of Vital Pulp Therapy on Permanent Dentition: A Systematic Review and Meta-Analysis of Randomized Controlled Trials10.1016/j.joen.2021.08.008 ↗
37. Outcome of Direct Pulp Capping in Teeth Diagnosed as Irreversible Pulpitis: Systematic Review and Meta-Analysis
38. Physicochemical Basis of the Biologic Properties of Mineral Trioxide Aggregate10.1097/01.DON.0000133155.04468.41 ↗
39. Calcium Silicate and Calcium Hydroxide Materials for Pulp Capping: Biointeractivity, Porosity, Solubility and Bioactivity of Current Formulations
40. Chemical–Physical Properties of TheraCal, a Novel Light-Curable MTA-like Material for Pulp Capping10.1111/j.1365-2591.2012.02013.x ↗
41. Sukajintanakarn, C., Sritanaudomchai, H., Laptanasupkun, P., and Pongprueksa, P. (2020, January 1). Pulpal Reaction to Pulp Capping Material In Human Tooth Culture Model. Proceedings of the RSU International Research Conference, Pathum Thani, Thailand.
42. Preclinical Effectiveness of an Experimental Tricalcium Silicate Cement on Pulpal Repair10.1016/j.msec.2020.111167 ↗
43. Manaspon, C., Jongwannasiri, C., Chumprasert, S., Sa-Ard-Iam, N., Mahanonda, R., Pavasant, P., Porntaveetus, T., and Osathanon, T. (2021). Human Dental Pulp Stem Cell Responses to Different Dental Pulp Capping Materials. BMC Oral Health, 21.10.1186/s12903-021-01544-w ↗
44. Cytotoxicity and Osteogenic Potential of Silicate Calcium Cements as Potential Protective Materials for Pulpal Revascularization10.1016/j.dental.2015.09.020 ↗
45. Effect of Light-Cured Pulp Capping Materials on Human Dental Pulp Cells in Vitro10.1111/iej.14242 ↗
46. Effects of BisGMA on Glutathione Metabolism and Apoptosis in Human Gingival Fibroblasts in Vitro10.1016/j.biomaterials.2003.11.048 ↗
47. Release and Toxicity of Dental Resin Composite10.4103/0971-6580.103652 ↗
48. Effect of TheraCal PT and Biodentine on Inflammatory Cell Infiltration and Hard Tissue Formation after Pulpotomy in Inflamed or Healthy Rat Molars10.1007/s00784-025-06372-8 ↗
49. Novotná, B., Holík, P., Morozova, Y., Rosa, M., Galandáková, A., and Langová, K. (2024). Evaluation of Cytotoxicity of the Dental Materials TheraCal LC, TheraCal PT, ApaCal ART and Biodentine Used in Vital Pulp Therapy: In Vitro Study. Dent. J., 12.10.3390/dj12080249 ↗
50. Comparative Chemical Properties, Bioactivity, and Cytotoxicity of Resin-Modified Calcium Silicate–Based Pulp Capping Materials on Human Dental Pulp Stem Cells10.1007/s00784-022-04713-5 ↗
51. Cytocompatibility and Bioactive Properties of the New Dual-Curing Resin-Modified Calcium Silicate-Based Material for Vital Pulp Therapy10.1007/s00784-021-03811-0 ↗
52. Biocompatibility and Bioactivity of a Dual-Cured Resin-Based Calcium Silicate Cement: In Vitro and in Vivo Evaluation10.1016/j.joen.2023.11.009 ↗
53. Quiñonez-Ruvalcaba, F., Bermúdez-Jiménez, C., Aguilera-Galavíz, L.A., Villanueva-Sánchez, F.G., García-Cruz, S., and Gaitán-Fonseca, C. (2023). Histopathological Biocompatibility Evaluation of TheraCal PT, NeoMTA, and MTA Angelus in a Murine Model. J. Funct. Biomater., 14.10.3390/jfb14040202 ↗
54. Comparative Biological Properties and Mineralization Potential of 3 Endodontic Materials for Vital Pulp Therapy: Theracal PT, Theracal LC, and Biodentine on Human Dental Pulp Stem Cells10.1016/j.joen.2021.08.001 ↗
55. In Vitro Bioactivity of Newly Introduced Dual-Cured Resin-Modified Calcium Silicate Cement10.4103/1735-3327.336686 ↗
56. Karahan, M., Eliacik, B.B.K., Cagiral, U., Iscan, E., and Ozhan, G. (2024). Investigation of the Biocompatibility of Various Pulp Capping Materials on Zebrafish Model. PLoS ONE, 19.10.1371/journal.pone.0310996 ↗
57. Biocompatibility and Cytotoxicity of Pulp-Capping Materials on DPSCs, with Marker MRNA Expressions10.1016/j.identj.2024.04.006 ↗
58. Nanchang, C., and Kouzmanova, Y. (2021, January 13–15). Analysis of the Organic Content in Two Hybrid Calcium-Silicate Cements. Proceedings of the 2021 International Symposium on Biomedical Engineering and Computational Biology, Nanchang, China.
59. Experimental Resin-Modified Calcium-Silicate Cement Containing N-(2-Hydroxyethyl) Acrylamide Monomer for Pulp Tissue Engineering10.1016/j.msec.2021.112105 ↗
60. Park, S.-M., Rhee, W.-R., Park, K.-M., Kim, Y.-J., Ahn, J., Knowles, J.C., Kim, J., Shin, J., Jang, T.-S., and Jun, S.-K. (2021). Calcium Silicate-Based Biocompatible Light-Curable Dental Material for Dental Pulpal Complex. Nanomaterials, 11.10.3390/nano11030596 ↗
61. Physical-Mechanical Properties o f a Resin-Modified Calcium Silicate Material for Pulp Capping10.1590/0103-6440202003079 ↗
62. In Vitro Comparison of Pushout Bond Strength of ProRoot MTA, Biodentine and TheraCal10.4317/jced.58893 ↗
63. Kim, M., Lee, S.-H., and Shin, D.-H. (2023). In Vitro Study of the Biological and Physical Properties of Dual-Cure Resin-Modified Calcium Silicate-Based Cement. Dent. J., 11.10.3390/dj11050120 ↗
64. Role of TheraCal LC in Pediatric Dentistry: A Narrative Review10.4103/jioh.jioh_122_21 ↗
65. Assessment of Pulp Chamber Morphology of Primary Maxillary and Mandibular Molars Using Spiral Computed Tomography: An Analytical Study10.5005/jp-journals-10005-3062 ↗
66. Vital Pulp Therapy with New Materials for Primary Teeth: New Directions and Treatment Perspectives10.1016/j.joen.2008.02.031 ↗